Pharmaceuticals as priority water contaminants

Toxicological and Environmental Chemistry

Volumn 92, Issue 3, 2010, Pages 549-565

  Bottoni, P ^a   Caroli, S ^a   Caracciolo, A Barra ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b WATER RESEARCH INSTITUTE   (Italy)

Author keywords

Drinking water; Metabolites; Pharmaceuticals; Surface water; Water contamination

Indexed keywords

ANTIBIOTIC RESISTANCE; AQUATIC BIOTA; AQUATIC ENVIRONMENTS; AQUATIC ORGANISMS; AQUATIC SPECIES; BIOCHEMICAL ACTIVITY; CHEMICAL-PHYSICAL PROPERTIES; DRINKING WATER; ENVIRONMENTAL BEHAVIOR; ENVIRONMENTAL QUALITY STANDARDS; EXPERIMENTAL EVIDENCE; HARMFUL EFFECTS; HUMAN HEALTH; INDUSTRIAL DISCHARGES; LIVESTOCK FARMING; PATHOGENIC MICROORGANISMS; PHARMACEUTICALS; SCIENTIFIC DATA; SEWAGE SYSTEM; WATER CONCENTRATIONS; WATER CONTAMINANTS; WATER FRAMEWORK DIRECTIVES; WATER MONITORING; WATERBODIES;

AGRICULTURE; ANTIBIOTICS; AQUACULTURE; BIODEGRADATION; BIOMOLECULES; HEALTH RISKS; INDUSTRIAL WATER TREATMENT; METABOLISM; METABOLITES; MICROORGANISMS; POTABLE WATER; RISK ASSESSMENT; RISK MANAGEMENT; SEWAGE; SEWAGE TREATMENT; SEWAGE TREATMENT PLANTS; SURFACE WATERS; WATER CONSERVATION; WATER POLLUTION;

EFFLUENTS;

ANTIBIOTICS; BIODEGRADATION; DRINKING WATER; DRUG; HEALTH RISK; LIVESTOCK FARMING; METABOLITE; PHYSICOCHEMICAL PROPERTY; POLLUTION MONITORING; RISK ASSESSMENT; SEWAGE DISPOSAL; SURFACE WATER; WATER POLLUTION;

EID: 77949363020     PISSN: 02772248     EISSN: 10290486     Source Type: Journal    
DOI: 10.1080/02772241003614320     Document Type: Review

References (43)

1. Andreozzi, R., M. Raffaele, and P. Nicklas. 2003. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50: 1319-30.
2. Atkinsons, S., M.J. Atkinsons, and A.M. Tarrant. 2003. Estrogens from sewage in coastal marine environments. Environmental Health Perspectives and Supplements 111: 531-5.
3. Austin, B. 1985. Antibiotic pollution from fish farms: Effects on aquatic microflora. Microbiological Sciences 2: 113-17.
4. Boon, P.I., and M. Cattanach. 1999. Antibiotic resistance of native and faecal bacteria isolated from rivers, reservoirs and sewage treatment facilities in Victoria, south-eastern Australia. Letters in Applied Microbiology 28: 164-8.
5. Boxall, A.B.A., D.W. Kolpin, B. Halling-Sorensen, and J. Tolls. 2003. Are veterinary medicines causing environmental risks? Environmental Science and Technology 37: 286A-94A.
6. Busani, L., C. Graziani, A. Franco, A. Di Egidio, E. Grifoni, G. Formato, M. Sala, N. Binkin, and A. Battisti. 2003. Antibiotics in cow environment: Results of a survey among veterinaries on this field, Gli antibiotici nell'ambiente bovino: Risultati di una indagine tra I veterinari del settore. Notiziario dell'Istituto Superiore di Sanità 16, Luglio-Agosto [in Italian].
7. Buser, H.R., and M.D. Muller. 1998. Occurrence of the pharmaceutical drug clofibric acid and herbicide mecoprop in various Swiss lakes and in the North Sea. Environmental Science and Technology 32: 188-92.
8. Calamari, D., D. Zuccato, S. Castiglioni, R. Bagnati, and R. Fanelli. 2003. Strategic survey of therapeutic drugs in the rivers Po and Lambro in Northern Italy. Environmental Science and Technology 37: 1241-8.
9. Christensen, F.M 1998. Pharmaceuticals in the environment: A human risk? Regulatory Toxicology and Pharmacology 28: 212-21.
10. CSTEE (Scientific Committee on Toxicity, Ecotoxicity and the Environment) 2001. Opinion on draft CPMP Discussion Paper on environmental risk assessment of medicinal products for human use (non-genetically modified organism (non-GMO) containing). Expressed at the 24th CSTEE plenary meeting, Brussels, June 12, 2001.
11. Daughton, C.G., and T.A. Ternes. 1999. Pharmaceutical and personal care products in the environment: Agents or subtle change? Environmental Health Perspectives 107: 907-48.
12. Directive 2000/60/EC of October 23, 2000 establishing a framework for community action in the field of water policy. O.J. L 327, December 22, 2000.
13. Directive 2008/105/EC of December 16, 2008 on environmental quality standards in the field of water policy, amending and subsequently repealing Council Directives 82/176/EEC, 83/513/EEC, 84/156/EEC, 84/491/EEC, 86/280/EEC and amending Directive 2000/60/EC of the European Parliament and of the Council.
14. Directive 2009/90/EC of July 31, 2009 laying down, pursuant to Directive 2000/60/EC of the European Parliament and of the Council, technical specifications for chemical analysis and monitoring of water status. O.J. L 201/36, August 1, 2009.
15. EMEA - CHMP (European Medicines Agency) - (Committee for Medicinal Products for Human Use). 2006. Guideline on the environmental risk assessment of medicinal products for human use. London, June 1, 2006. Doc. Ref. EMEA/CHMP/SWP/4447/00.
16. European Chemical Bureau 2003. Technical Guidance Document in support of Commission Directive 93/67/EEC on risk assessment for new notified substances, Commission Regulation (EC) No 1488/94 on risk assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market.
17. Grung, M., T. Källqvist, S. Sakshaug, S. Skurtveit, and K.V. Thomas. 2008. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicology and Environmental Safety 71: 328-40.
18. Halling-Sorensen, B., S. Nors Nielsen, P.F. Lanzky, F. Ingerslev, H.C. Holten Lutzhoft, and S.E. Jorgensen. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment - A review. Chemosphere 36: 357-93.
19. IARC (International Agency for Research on Cancer) 2005. Cancer databases. IARC monographs databases on carcinogenic risk to humans. Complete list of agents, mixtures and exposures evaluated and their classification. http://monographs.iarc.fr/ENG/Classification/index.php
20. Italian Ministry of Health 2001. Synthesis and upgrading of the report: The use of pharmaceuticals in Italy. National Report January-September 2001, Sintesi ed aggiornamento del rapporto: L'uso dei farmaci in Italia. Rapporto Nazionale gennaio-settembre 2001 [in Italian]. Roma: Direzione Generale della Valutazione dei Medicinali e della Farmacovigilanza.
21. Jones, O.A., N. Voulvoulis, and J.N. Lester. 2002. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 36: 5013-22.
22. Kolpin, D.W., E.T. Furlong, M.T. Meyer, E.M. Thurman, S.D. Zaugg, L.B. Barber, and H.T. Buxton. 2002. Pharmaceuticals, hormones, and other wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environmental Science and Technology 36: 1202-11.
23. Koschorreck, J., C. Koch, and I. Rönnefahrt. 2002. Environmental risk assessment of veterinary medicinal products in the EU - A regulatory perspective. Toxicology Letters 131: 117-24.
24. Lalumera, G.M., D. Calamari, P. Galli, S. Castiglioni, S. Crosa, and R. Fanelli. 2004. Preliminary investigation on the environmental occurrence and effects of antibiotics used in aquaculture in Italy. Chemosphere 54: 661-8.
25. Larsson, D.G.J., M. Adolfsson-Erici, J. Parkkonen, M. Pettersson, A.H. Berg, P.E. Olsson, and L. Fölin. 1999. Ethinyloestradiol - An undesired fish contraceptive? Aquatic Toxicology 45: 91-7.
26. Migliore, L., S. Cozzolino, and M. Fiori. 2003. Phytotoxicity to and uptake of enrofloxacin in crop plants. Chemosphere 52: 1233-44.
27. Miranda, C.D., and G. Castillo. 1998. Resistance to antibiotic and heavy metals of motile aeromonads from Chilean freshwater. Science of the Total Environment 224: 167-76.
28. Reddersen, K., T. Heberer, and U. Dunnbier. 2002. Identification and significance of phenazone drugs and their metabolites in ground and drinking water. Chemosphere 49: 539-44.
29. Routledge, E.J., D. Sheahan, C. Desbrow, G.C. Brighty, M. Waldock, and J.P. Sumpter. 1998. Identification of estrogenic chemicals in STW effluent 2: In vivo responses in trout and roach. Environmental Science and Technology 32: 1559-65.
30. RxList, The Internet Drug Index. 2005. Top 200 Drugs. U.S. Only - By prescription dispensed. Data uploaded on the website: http://www.rxlist.com/script/main/hp.asp/ (accessed March 2005).
31. Sacher, F., F.T. Lange, H.-J. Brauch, and I. Blankernhorn. 2001. Pharmaceuticals in groundwater. Analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany. Journal of Chromatography A 938: 199-210.
32. Schwab, B.W., E.P. Hayes, J.M. Fiori, F.J. Mastrocco, N.M. Roden, D. Cragin, R.D. Meyerhoff, V.J. D'Aco, and P.D. Anderson. 2005. Human pharmaceuticals in US surface waters: A human health risk assessment. Regulatory Toxicology and Pharmacology 42: 296-312.
33. Steger-Hartmann, T., K. Kummerer, and A. Hartmann. 1997. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicology and Environmental Safety 36: 174-9.
34. Steger-Hartmann, T., R. Lange, and H. Schweinfurth. 1999. Environmental risk assessment for the widely used iodinate X-ray contrast agent isopromide (Ultravist). Ecotoxicology and Environmental Safety 42: 274-1.
35. Stuer-Lauridsen, F., M. Birkved, L.P. Hansen, H.C.H. Lutzhoft, and B. Halling-Sorensen. 2000. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40: 783-93.
36. Stumpf, M., T.A. Ternes, R.D. Wilken, S.V. Rodrigues, and W. Baumann. 1999. Polar drugs residues in sewage and natural waters in the state of Rio de Janeiro. Science of the Total Environment 225: 135-41.
37. The Merck Index 1996. In An encyclopaedia of chemicals, drugs, and biologicals. 12th ed. eds. S. Budavari, M. O'Neil, A. Smith, P.E. Heckelman and J.F. Kinneary, Whitehouse Station, NJ: Merck & Company.
38. Tixier, C., H.P. Singer, S. Oellers, and S.R. Muller. 2003. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen and naproxen in surface waters. Environmental Science and Technology 37: 1061-8.
39. TOXNET Toxicology Data Network - Hazardous Substances Data Bank (HSDB). 2009. United States National Library of Medicine. Data uploaded on the website: http://toxnet.nlm.nih.gov/ (accessed December 2009).
40. Webb, S., T. Ternes, M. Gibert, and K. Olenjniczac. 2003. Indirect human exposure to pharmaceuticals via drinking water. Toxicology Letters 142: 157-67.
41. WHO (World Health Organization) 1999. In Safe management of wastes from health-care activities, eds. A. Prüss, E. Giroult and P. Rushbrook, Geneva: World Health Organization (WHO).
42. Winkler, M., J.R. Lawrence, and T.R. Neu. 2001. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Research 35: 3197-205.
43. Zuccato, E., D. Calamari, M. Natangelo, and R. Fanelli. 2000. Presence of therapeutic drugs in the environment. Lancet 355: 1789-90.